BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loconsole D, Giordano M, Laforgia N, Torres D, Santangelo L, Carbone V, Parisi A, Quarto M, Scavia G, Chironna M; Bloody Diarrhea Apulia Working Group. Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy. Eur J Clin Microbiol Infect Dis 2020;39:539-47. [PMID: 31776873 DOI: 10.1007/s10096-019-03755-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Michelacci V, Montalbano Di Filippo M, Gigliucci F, Arancia S, Chiani P, Minelli F, Roosens NHC, De Keersmaecker SCJ, Bogaerts B, Vanneste K, Morabito S. Population Analysis of O26 Shiga Toxin-Producing Escherichia coli Causing Hemolytic Uremic Syndrome in Italy, 1989–2020, Through Whole Genome Sequencing. Front Cell Infect Microbiol 2022;12:842508. [DOI: 10.3389/fcimb.2022.842508] [Reference Citation Analysis]
2 Castellano-Martínez A, Roldan-Cano V, Rodríguez-González M. Factors associated with the development of renal sequelae in a series of cases with Shiga toxin hemolytic-uremic syndrome. Med Clin (Barc) 2021;157:449-50. [PMID: 33272684 DOI: 10.1016/j.medcli.2020.09.010] [Reference Citation Analysis]
3 Loconsole D, Giordano M, Centrone F, Accogli M, Casulli D, De Robertis AL, Morea A, Quarto M, Parisi A, Scavia G, Chironna M, On Behalf Of The Bloody Diarrhea Apulia Working Group. Epidemiology of Shiga Toxin-Producing Escherichia coli Infections in Southern Italy after Implementation of Symptom-Based Surveillance of Bloody Diarrhea in the Pediatric Population. Int J Environ Res Public Health 2020;17:E5137. [PMID: 32708640 DOI: 10.3390/ijerph17145137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Pesce F, Stea ED, Rossini M, Fiorentino M, Piancone F, Infante B, Stallone G, Castellano G, Gesualdo L. Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention. Front Med (Lausanne) 2020;7:582272. [PMID: 33738291 DOI: 10.3389/fmed.2020.582272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pang JX, Singh J, Freedman SB, Xie J, Hu J. Improving follow-up testing in children with Shiga toxin-producing Escherichia coli through provision of a provider information sheet. Aust J Prim Health 2020;26:479-83. [PMID: 33296623 DOI: 10.1071/PY20136] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Santangelo L, Netti GS, Torres DD, Piscopo G, Carbone V, Losito L, Milella L, Lasorella ML, Conti P, Gagliardi D, Chironna M, Spadaccino F, Bresin E, Trabacca A, Ranieri E, Giordano M. Peripheral nervous system manifestations of Shiga toxin-producing E. coli-induced haemolytic uremic syndrome in children. Ital J Pediatr 2021;47:181. [PMID: 34488831 DOI: 10.1186/s13052-021-01133-1] [Reference Citation Analysis]